Didanosine Capsules bulk supplier for pharma manufacturers

Didanosine Capsules 250 mg, 400 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 250 mg, 400 mg

Reference Brands: Videx EC (USA/EU)

Didanosine delayed-release capsules 250 mg and 400 mg, an older once-daily nucleoside antiretroviral for HIV now used rarely. For hospital pharmacies and licensed importers where it remains registered.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Didanosine Capsules? List it or send an offer →

Product Description:

Didanosine is a purine nucleoside reverse transcriptase inhibitor, an analogue of deoxyadenosine that the cell converts to an active triphosphate, which ends the growing viral DNA chain. Stomach acid destroys it, which is why early forms were chewable buffered tablets or powders. The 250 mg and 400 mg capsules on this page are the delayed-release form: enteric-coated beadlets inside a capsule that protect the drug through the stomach and allow one capsule a day, swallowed whole.

WHO guidelines and major regulators have moved to safer regimens, and didanosine is now used rarely, only where it is still registered and a specialist judges it necessary. The 400 mg dose is for adults of 60 kg or more and 250 mg for lighter adults, taken on an empty stomach. Pancreatitis, peripheral neuropathy, lactic acidosis and non-cirrhotic portal hypertension are the major risks. Combination with stavudine is contraindicated, particularly in pregnancy. Allopurinol and ribavirin must not be given with it, and tenofovir disoproxil raises didanosine levels.

Sourcing notes. First confirm that the product still has a valid registration in the destination and that a prescriber has a clear need, since many guidelines no longer list it. Ask for a CoA per batch including assay, related substances and acid-resistance testing of the enteric-coated beadlets, together with the GMP certificate, a CoPP and the dossier. Capsules are packed in bottles with desiccant at room temperature; there is no cold chain, but ask for zone IVb stability data. State strength, quantity and remaining shelf life needed, as low-volume products can be short-dated.

Didanosine Capsules — third party manufacturing & bulk supply

Didanosine Capsules 250 mg, 400 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Didanosine Capsules is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Didanosine Capsules listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Didanosine Capsules →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Didanosine is used for the treatment of HIV-1 infection as part of combination antiretroviral therapy. It helps reduce viral load, improve immune response, and slow disease progression in patients living with HIV.

Didanosine is made from the active ingredient didanosine, a synthetic nucleoside analogue of deoxyadenosine. It works by inhibiting the HIV reverse transcriptase enzyme, blocking viral replication.

The commonly known trade names for didanosine are Videx and Videx EC.

Videx and Videx EC were originally developed and marketed by Bristol-Myers Squibb. Many other pharmaceutical manufacturers also produce generic didanosine in various dosage forms.

The generic name is didanosine.

Brand names include Videx, Videx EC, and several generic equivalents depending on the manufacturer.

Didanosine is manufactured by various approved pharmaceutical companies in India, the United States, Europe, and other global regions depending on the brand or generic version.